Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 11, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	579	518	125	589	2,339	4,749
Market Cap Growth	-4.45%	315.99%	-78.86%	-74.81%	-50.75%	70.50%
Enterprise Value	1,005	1,044	917	1,414	2,824	5,255
Last Close Price	11.03	9.56	2.40	11.81	43.47	89.60
PE Ratio	8.17	-	-	-	10.65	15.53
Forward PE	3.71	12.57	-	51.15	7.19	9.53
PS Ratio	0.75	0.50	0.12	0.53	1.32	3.01
PB Ratio	1.00	1.07	0.19	0.43	1.45	3.28
P/TBV Ratio	4.46	-	1.51	1.34	2.99	9.18
P/FCF Ratio	413.78	14.47	-	-	24.34	12.02
P/OCF Ratio	44.56	8.82	-	-	7.30	8.85
PEG Ratio	-	-	-	11.76	0.21	0.68
EV/Sales Ratio	1.27	1.00	0.87	1.26	1.59	3.33
EV/EBITDA Ratio	4.57	19.55	-	90.08	5.60	8.63
EV/EBIT Ratio	8.11	-	-	-	7.32	10.53
EV/FCF Ratio	717.71	29.17	-	-	29.39	13.30
Debt / Equity Ratio	1.15	1.40	1.35	1.03	0.54	0.64
Debt / EBITDA Ratio	3.05	12.66	-	90.85	1.72	1.50
Debt / FCF Ratio	479.29	18.89	-	-	9.13	2.34
Asset Turnover	0.54	0.65	0.42	0.37	0.61	0.61
Inventory Turnover	1.19	2.29	2.34	2.38	3.01	2.70
Quick Ratio	2.89	1.56	0.47	0.66	2.29	2.22
Current Ratio	5.77	3.69	1.04	0.99	3.40	3.11
Return on Equity (ROE)	13.91%	-33.67%	-74.67%	-14.11%	14.35%	24.12%
Return on Assets (ROA)	5.27%	-2.03%	-4.21%	-2.23%	8.26%	11.98%
Return on Invested Capital (ROIC)	9.09%	-4.22%	-9.40%	-5.36%	15.27%	21.13%
Return on Capital Employed (ROCE)	9.40%	-4.30%	-14.30%	-5.60%	14.90%	20.00%
Earnings Yield	13.10%	-36.80%	-610.73%	-35.91%	9.39%	6.44%
FCF Yield	0.24%	6.91%	-207.11%	-25.44%	4.11%	8.32%
Buyback Yield / Dilution	-6.86%	-3.52%	-2.20%	7.39%	-0.56%	-2.67%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q